Epinephrine: Clinical Trials

40 trials of Epinephrine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

27 completed, 4 terminated, 4 unknown, 2 recruiting. 40 Phase 1, 17 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 140Completed 27, Terminated 4, Unknown 4, Recruiting 2, Active not recruiting 1, Enrolling by invitation 1, Withdrawn 1
Phase 217Completed 10, Terminated 2, Unknown 2, Enrolling by invitation 1, Recruiting 1, Withdrawn 1

Follow Epinephrine: new trials by email Literature Review of Epinephrine trials Research Report on Epinephrine

Trials (filtered) newest first · largest first

All 40 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ESP Blocks in Breast Free Flaps
Bupivacaine with Epinephrine and Dexamethasone - Breast Reconstruction, Free Flap Reconstruction
Phase 1RecruitingCarilion Clinic602026-10-012026-10-23
Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis
FMXIN002 single dose, Epinephrine autoinjector single dose, FMXIN002 single dose + NAC - Anaphylaxis, Allergy
Phase 1 / Phase 2Enrolling by invitationNasus Pharma502025-11-032025-11-14
PK/PD Study of IN-001 Sublingual Spray in Healthy Adults
Epinephrine Auto-Injector 0.3 mg/0.3 mL, Epinephrine 0.3 mg intramuscular manual injection via a syringe and needle, IN-001 9.06 mg Sublingual Spray - Food Allergy, Anaphylaxis
Phase 1CompletedInsignis Therapeutics, Inc.322025-10-242026-05-05
Effect of RECK in Posterior Spinal Fusion
Ropivacaine, Epinephrine, Clonidine, and Ketorolac Injection Cocktail, Placebo - Degenerative Lumbar Spinal Stenosis, Degenerative Disc Disease
Phase 1 / Phase 2WithdrawnUniversity of Maryland, Baltimore2025-10-012025-07-31
COntralateral CorticoSTeroid Injection in Total Knee Arthroplasty
Corticosteroid Injection - 80mg methylprednisolone (total volume 2ml) with 6 mL of 1% Bupivacaine without epinephrine (Total Volume 8 mL)., Band-Aid - Total Knee Anthroplasty, Osteoarthritis(Primary)
Phase 1 / Phase 2RecruitingUnity Health Toronto602025-01-242026-07-30
Risk of Nerve Damage After Administration of Local Anesthesia
4% Articaine with 1:200,000 epinephrine, 2% lidocaine with 1:100,000 epinephrine - Inferior Alveolar Nerve Injuries
Phase 1UnknownCleveland Dental Institute802024-01-012024-08-26
Vasopressin vs. Epinephrine During Neonatal Cardiopulmonary Resuscitation
Vasopressin, Epinephrine - Cardiac Arrest Neonatal
Phase 1Active not recruitingUniversity of Alberta82023-11-272026-04-09
Study of Inhaled DMC-IH1 and Intramuscular (EpiPen®) Epinephrine in Healthy Male and Female Participants.
Epinephrine, Placebo - Anaphylactic Reaction
Phase 1CompletedDe Motu Cordis242023-10-242024-08-20
Comparative Bioavailability of Intranasal Epinephrine
A: Epinephrine injection, B: FMXIN002 3.6mg, C: FMXIN002 4.0mg - Anaphylaxis, Anaphylactic Reaction
Phase 1 / Phase 2CompletedNasus Pharma122023-08-222025-06-18
Evaluating Efficacy of Intravenous Carbetocin Versus Intramyometrial Injection of Adrenaline in Reducing Blood Loss
Carbetocin - Uterine Fibroid
Phase 1CompletedEgymedicalpedia622023-02-012023-10-17
"The Effect Of Subcutaneous Epinephrine Dosage On Blood Loss In Surgical Incision"
Epinephrine injection - To Determine the Optimal Doses of Adrenaline in Preventing Blood Loos in Participants Undergoing Supraclavicular Flap Surgery
Phase 1UnknownDow University of Health Sciences902023-02-012023-01-04
Study of Inhaled Epinephrine and Intramuscular Epinephrine Administered to Healthy Adults
EpiPen ®., Epinephrine (0.3mg) inhaled, Epinephrine (1.3mg) - Anaphylactic Reaction
Phase 1CompletedDe Motu Cordis232022-01-062023-07-24
Pain Control Following Total Hip Arthroplasty
Bupivacaine Hydrochloride 0.25% Injection Solution_#2, EPINEPHrine 1:200,000 / Prilocaine HCl 4 % 1.8 ML Cartridge, Bupivacaine Hydrochloride 0.5% Injection Solution_#2 - Chronic Postoperative Pain
Phase 1CompletedSt. Mary's Research Center, Canada2402021-11-042024-08-16
Pharmacokinetics of Adrenaline After Administration of ARS -1 in Subjects With Upper Respiratory Tract Infection
ARS-1 with URTI, ARS-1 without URTI - Upper Respiratory Tract Infection
Phase 1CompletedARS Pharmaceuticals, Inc.152021-08-092022-07-29
Bioavailability of Nasal Epinephrine
Epinephrine Nasal Product, 1.6 mg, Epinephrine nasal product, 1.6 mg + allergen, Epinephrine Injection 0.3 mg - Anaphylaxis
Phase 1CompletedNasus Pharma122020-11-012024-01-05
Functional Endoscopic Sinus Surgery Study
Bupivacaine or Ropivacaine with epinephrine plus dexamethasone - Group 1, Bupivacaine or Ropivacaine with epinephrine plus dexamethasone - Group 2 - Chronic Rhinosinusitis (Diagnosis)
Phase 1 / Phase 2CompletedUniversity of Florida802019-09-252026-07-30
Articaine Efficacy and Safety for Children Below Age of 4-years
Articaine 4%/Epi 1:100000 Inj Cart 1.7Ml, lidocaine hydrochloride 2% and epinephrine 1:100000 - Behaviour Assessment, Pain
Phase 1 / Phase 2CompletedMinia University1842019-08-252020-02-17
Microneedle Pretreatment as a Strategy to Improve the Effectiveness of Topical Anesthetics Formulations
Topical Anesthetic, Local anesthetic - Oral Cavity Disease
Phase 1CompletedUniversity of Campinas, Brazil302019-08-012022-03-21
Can Epinephrine Coated Syringe for Subcutaneous Immunotherapy (SCIT) Reduce Large Local Reaction?
Epinephrine or normal saline - Injection Reactions Site, Systemic Reactions
Phase 1 / Phase 2CompletedMahidol University172018-10-242020-02-20
M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers
M7824, Topotecan, Temozolomide - Carcinoma, Small Cell, Lung Cancer
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)372018-09-112025-05-09

Showing 20 of 40. Sign in to see all of them.

Conditions studied

Anaphylaxis (6)  ·  Asthma (4)  ·  Agnosia (3)  ·  Pain, Postoperative (3)  ·  Dyspnea (2)  ·  Lung Neoplasms (2)  ·  Lymphoma (2)  ·  Pain (2)  ·  Respiratory Sounds (2)  ·  Bronchial Spasm (1)  ·  Carcinoma, Small Cell (1)  ·  Dental Caries (1)  ·  Diabetes Insipidus (1)  ·  Disease (1)  ·  Food Hypersensitivity (1)

Sponsors

Amphastar Pharmaceuticals, Inc. (4)  ·  Nasus Pharma (3)  ·  National Cancer Institute (NCI) (3)  ·  De Motu Cordis (2)  ·  Rutgers, The State University of New Jersey (2)  ·  University of Campinas, Brazil (2)  ·  University of Florida (2)  ·  ARS Pharmaceuticals, Inc. (1)  ·  Carilion Clinic (1)  ·  Charles Berde (1)  ·  Cleveland Dental Institute (1)  ·  Dow University of Health Sciences (1)  ·  Egymedicalpedia (1)  ·  Grünenthal GmbH (1)  ·  Insignis Therapeutics, Inc. (1)

Countries

United States (20)  ·  Canada (4)  ·  Australia (3)  ·  Brazil (3)  ·  Egypt (2)  ·  Israel (2)  ·  Thailand (2)  ·  Netherlands (1)  ·  Pakistan (1)  ·  Sweden (1)

Top investigators

Siobhan Corbett, MD (2)  ·  Ahmad Elheeny (1)  ·  Ahmed A Hashem, PhD (1)  ·  Alain Mina, M.D. (1)  ·  Alice P Chen, M.D. (1)  ·  Amir Khoshbin, MD, FRCS (C) (1)  ·  Anders Jeppsson, MD,PhD,Prof (1)  ·  Anish Thomas, M.D. (1)  ·  Anthony McGirr, MD (1)  ·  Benno von Bormann, MD (1)  ·  Benny Weksler, MD (1)  ·  Cameron R Smith (1)  ·  Dr. Anthony Albers, MDCM, FRCSC (1)  ·  Georg Schmolzer (1)

Results publications

PMID 10212363, PMID 1053919, PMID 10709851, PMID 10717828, PMID 10895619, PMID 10916328, PMID 11139785, PMID 11199555, PMID 11321382, PMID 11409642, PMID 1157366, PMID 1170757, PMID 11875603, PMID 12436828, PMID 12685620, PMID 12723166, PMID 12767443, PMID 12873775, PMID 13263433, PMID 14446037, PMID 1452871, PMID 14894244, PMID 15190533, PMID 15793381, PMID 15851928, PMID 15917682, PMID 16022946, PMID 16175029, PMID 16175030, PMID 16648419, PMID 16695846, PMID 17650835, PMID 1812051, PMID 19387330, PMID 1984216, PMID 20006669, PMID 21195945, PMID 21831487, PMID 22106246, PMID 2213464, PMID 2263330, PMID 2365491, PMID 26056838, PMID 2705548, PMID 27131, PMID 30734772, PMID 30780166, PMID 3125267, PMID 3164019, PMID 32150492

NIH funding

2016 (1)